Alpha Cognition Inc (TSE:ACOG) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Alpha Cognition Inc., a biopharmaceutical firm focusing on neurodegenerative diseases, has announced the resignation of CFO Don Kalkofen and the interim appointment of Jay Yoo, an experienced CPA and CFA. The company has recently achieved significant milestones, including the approval of their Alzheimer’s treatment ZUNVEYL, and is preparing for its early 2025 launch.
For further insights into TSE:ACOG stock, check out TipRanks’ Stock Analysis page.
